Michael Lee, MD
Dermatology · San Diego, CANPI 1255607685
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,566 of the $17,153 with a category attached, or 73.3%. It is spread thinly across 28 manufacturers, the largest accounting for just 21.0%. Reporting peaked in 2024 at $5,930 and has fallen 57.0% since, to $2,547 in 2025.
Across 380 payments — averaging $45.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$4K
- UCB, Inc.$3K
- Sun Pharmaceutical Industries Inc.$1K
- Dermavant Sciences, Inc.$1K
- AbbVie$1K
- Johnson & Johnson$1K
- plus $6K from 22 others
Across 14 payments — averaging $8330.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$117K
What the payments were for
- Consulting fees$3,93823%
- Travel & lodging$350%
- Food & beverage$12,56673%
- Education$6144%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 22 | $3,599 |
| UCB, Inc. | 29 | $2,958 |
| Sun Pharmaceutical Industries Inc. | 32 | $1,425 |
| Dermavant Sciences, Inc. | 20 | $1,301 |
| AbbVie | 58 | $1,291 |
| Johnson & Johnson(2 entities) | 22 | $1,034 |
| Pfizer | 43 | $936 |
| Lilly USA, LLC | 29 | $766 |
| Sanofi | 15 | $651 |
| Regeneron Healthcare Solutions, Inc. | 23 | $536 |
| Amgen | 16 | $534 |
| Arcutis Biotherapeutics, Inc. | 13 | $379 |
| Incyte Corporation | 13 | $324 |
| Galderma Laboratories, L.p. | 11 | $227 |
| Sanofi-aventis U.S. LLC | 2 | $199 |
| LEO Pharma Inc. | 8 | $170 |
| VYNE Pharmaceuticals Inc. | 3 | $132 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $128 |
| Dermira, Inc. | 1 | $124 |
| Prugen, Inc. Pharmaceuticals | 1 | $105 |
| Genentech, Inc. | 2 | $83 |
| Novartis | 2 | $58 |
| Almirall LLC | 2 | $52 |
| Organon | 2 | $40 |
| Cipher Pharmaceuticals US LLC | 1 | $38 |
| Hospira, Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $24 |
| Tempus AI, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,153 in reported general payments places this provider in the 85th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 46 | $2,907 |
| Clobetasol Propionate | 23 | $1,024 |
| Gentamicin Sulfate | 49 | $937 |
| Ketoconazole | 52 | $747 |
| Fluocinonide | 19 | $523 |
| Doxycycline Monohydrate | 26 | $491 |
| Triamcinolone Acetonide | 39 | $419 |
| MethotrexateMethotrexate Sodium | 11 | $414 |
| ValacyclovirValacyclovir Hcl | 17 | $106 |
Paid to pharmacies, not to this prescriber.
Other dermatology in San Diego
- Neal BhatiaSan Diego$2.5M
- Arisa OrtizSan Diego$261K
- Michael BradshawSan Diego$143K
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.